BCL2L1 and cancer: Therefore, we finally sought to determine whether the apparent pan-sensitivity of TIS cancer cells to BCL-xL-specific BH3 mimetics regardless the mitochondrial priming status can also occur when the acquisition of the TIS phenotype is transient.